[1]
Surajmal G. Malpani et al. 2025. A Study on the Molecular Docking of Quinazolin-4(3H)-One Derivatives against GABAa Receptor: A Novel Approach to Epilepsy Treatment. Achievements and Challenges of Medicine and Medical Science Vol. 11. (Jan. 2025), 119–127. DOI:https://doi.org/10.9734/bpi/acmms/v11/2898.